| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
Rachel Altshuler, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
Rachel Altshuler, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
Rachel Altshuler, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
Rachel Altshuler, Ph.D. |
| Hruska, Carrie B |
Mayo Clinic Rochester
United States |
Density MATTERS Clinical Trial |
5R01CA239200-04 |
Claire Zhu, Ph.D. |
| Peters, Jeffrey M |
Pennsylvania State University, The
United States |
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy |
5R01CA239256-05 |
Marjorie Perloff, M.D. |
| Palesh, Oxana G |
Virginia Commonwealth University
United States |
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia |
5R01CA239714-06 |
Marge Good, R.N., M.P.H., O.C.N. |
| Feliciano, Elizabeth Marjorie Cespedes |
Kaiser Foundation Research Institute
United States |
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients |
5R01CA240394-04 |
Gabriela Riscuta, M.D., C.N.S. |
| Feliciano, Elizabeth Marjorie Cespedes |
Kaiser Foundation Research Institute
United States |
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients |
5R01CA240394-04 |
Gabriela Riscuta, M.D., C.N.S. |
| Feliciano, Elizabeth Marjorie Cespedes |
Kaiser Foundation Research Institute
United States |
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients |
5R01CA240394-04 |
Gabriela Riscuta, M.D., C.N.S. |